Robert Roskoski
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Molecular Biology top 0.2%
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer
- Melanoma and MAPK Pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 20
- Protein Kinase Regulation and GTPase Signaling 19
- Biochemical and Molecular Research 16
- Melanoma and MAPK Pathways 13
- Ion channel regulation and function 12
- Oncology 33
- Co-authors
- Kent E. Vrana (9 shared papers)Fabian Hartl (5 shared papers)Fritz Lipmann (8 shared papers)Horst Kleinkauf (7 shared papers)Paul Cook (1 shared paper)Deepak Bhatnagar (9 shared papers)Wieland Gevers (5 shared papers)Phillip G. Schmid (12 shared papers)
- Journals
- Pharmacological Research (47 papers)Biochemistry (21 papers)Biochemical and Biophysical Research Communications (16 papers)Journal of Neurochemistry (14 papers)Archives of Biochemistry and Biophysics (6 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Robert Roskoski
167 papers receiving 14.8k citations
Robert Roskoski's Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 4.1k
- Molecular Biology 9.9k
- Genetics 1.1k
- Cancer Research 1.4k
- Cell Biology 1.3k
Countries citing papers authored by Robert Roskoski
This map shows the geographic impact of Robert Roskoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Roskoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Roskoski more than expected).
Fields of papers citing papers by Robert Roskoski
This network shows the impact of papers produced by Robert Roskoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Roskoski. The network helps show where Robert Roskoski may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Roskoski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ERK1/2 MAP kinases: Structure, function, and regulation Hit paper breakdown → | 2012 | 1222 |
| 2 | The ErbB/HER family of protein-tyrosine kinases and cancer Hit paper breakdown → | 2013 | 1043 |
| 3 | [1] Assays of protein kinase Hit paper breakdown → | 1983 | 797 |
| 4 | Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes Hit paper breakdown → | 2015 | 620 |
| 5 | 2007 | 482 | |
| 6 | 2005 | 477 | |
| 7 | 2004 | 456 | |
| 8 | Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors Hit paper breakdown → | 2015 | 455 |
| 9 | Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update Hit paper breakdown → | 2019 | 424 |
| 10 | Properties of FDA-approved small molecule protein kinase inhibitors Hit paper breakdown → | 2019 | 400 |
| 11 | 2015 | 376 | |
| 12 | Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers Hit paper breakdown → | 2018 | 363 |
| 13 | 2007 | 345 | |
| 14 | 1975 | 333 | |
| 15 | 1982 | 329 | |
| 16 | 2004 | 309 | |
| 17 | Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs Hit paper breakdown → | 2018 | 303 |
| 18 | 2016 | 288 | |
| 19 | 2010 | 272 | |
| 20 | Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update Hit paper breakdown → | 2021 | 269 |
About Robert Roskoski
Robert Roskoski is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Cell Biology and Genetics, having authored 173 papers that have together received 16.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (20 papers), Protein Kinase Regulation and GTPase Signaling (19 papers), Biochemical and Molecular Research (16 papers), Chronic Lymphocytic Leukemia Research (14 papers), Melanoma and MAPK Pathways (13 papers), Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (12 papers) and Amino Acid Enzymes and Metabolism (11 papers). The work is most often cited by research in Oncology (4.1k citations), Molecular Biology (9.9k citations), Genetics (1.1k citations), Cancer Research (1.4k citations) and Cell Biology (1.3k citations). Robert Roskoski has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Kent E. Vrana, Fabian Hartl, Fritz Lipmann, Horst Kleinkauf, Paul Cook, Deepak Bhatnagar, Wieland Gevers, Phillip G. Schmid, Abdollah Sadeghi‐Nejad and Alan H. Stokes. Their work appears in journals such as Pharmacological Research, Biochemistry, Biochemical and Biophysical Research Communications, Journal of Neurochemistry and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.